Start › Nowotwór przerzutowy › Karolina Północna › Durham
Badania kliniczne dla Nowotwór przerzutowy w mieście Durham, NC
33 badań dla Nowotwór przerzutowy szuka uczestników w ośrodkach w mieście Durham i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
RekrutacjaFaza 1/2
- Avenzo Therapeutics Recruiting Site, Chapel Hill · 10 mi dalej
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekrutacjaFaza 2
- Duke University Medical Center, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekrutacjaFaza 1/2
- Duke University, Durham
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekrutacjaFaza 2/3
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekrutacjaFaza 3
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekrutacjaFaza 2
- Duke Cancer Institute, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekrutacjaFaza 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mi dalej
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekrutacjaFaza 3
- Duke Cancer Institute, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekrutacjaFaza 3
- University of North Carolina Medical Center, Chapel Hill · 10 mi dalej
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10 mi dalej
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekrutacjaFaza 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · 10 mi dalej
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Duke University, Durham
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Rekrutacja
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi dalej
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekrutacjaFaza 1
- Duke Cancer Center, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Research Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekrutacjaFaza 1
- Research Site, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekrutacjaFaza 1
- Duke Cancer Center, Durham
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RekrutacjaFaza 1/2
- Duke University Medical Center, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
RekrutacjaBadanie obserwacyjne
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
UNC Metastatic Cancer Radiation Therapy Registry
RekrutacjaBadanie obserwacyjne
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi dalej
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
RekrutacjaFaza 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RekrutacjaFaza 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekrutacjaFaza 2/3
- Duke University Medical Center, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RekrutacjaFaza 1/2
- Duke Cancer Center/ DUMC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekrutacjaFaza 1
- Duke Cancer Institute, Durham
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
RekrutacjaFaza 3
- Duke University, Durham
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
RekrutacjaBadanie obserwacyjne
- Durham Veterans Administration Health Care System (DVAHCS), Durham
- Duke University Medical Center, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
RekrutacjaFaza 1
- Duke Cancer Center, Durham
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
RekrutacjaFaza 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi dalej
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
RekrutacjaFaza 1
- Duke University Medical Center - Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi dalej
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
RekrutacjaFaza 3
- Duke University - Trent Center, Durham
A Study of NX-1607 in Adults With Advanced Malignancies
RekrutacjaFaza 1
- University of North Carolina, Chapel Hill · 10 mi dalej
Badania dla Nowotwór przerzutowy w innych miastach
- Houston, TX104 badań
- New York City, NY93 badań
- Nashville, TN70 badań
- Boston, MA63 badań
- Los Angeles, CA57 badań
- St. Louis, MO54 badań
- Arlington, VA53 badań
- Philadelphia, PA46 badań
- Chicago, IL45 badań
- San Antonio, TX44 badań
- Washington, DC43 badań
- Dallas, TX42 badań
Inne badania w mieście Durham
- Rak piersi64 badań
- Nowotwory (wszystkie typy)58 badań
- Niedrobnokomórkowy rak płuca39 badań
- Szpiczak mnogi37 badań
- Ostra białaczka szpikowa33 badań
- Rak prostaty32 badań
- Rak płuc32 badań
- Rak jelita grubego i odbytnicy28 badań
- Rak jajnika27 badań
- Przewlekła białaczka limfocytowa27 badań
- Niewydolność serca26 badań
- Rak trzustki24 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.